Cancer risk in patients with systemic lupus erythematosus: a population-based cohort study in the Republic of Korea 2004–2021
Patients with SLE have increased cancer risk compared with the general population. Increased relative cancer risk is associated with younger age, first year post-diagnosis, and cyclophosphamide treatment.
Authors
- Doo‐Ho Lim (ORCID: https://orcid.org/0000-0002-8012-7364)
- Sojeong Park (ORCID: https://orcid.org/0000-0001-6019-6912)
- Minae Park (ORCID: https://orcid.org/0000-0003-3703-4514)
- Su Jin Choi (ORCID: https://orcid.org/0000-0002-9977-6444)
- Seung Won Choi (ORCID: https://orcid.org/0000-0001-5767-221X)
- Sunggun Lee (ORCID: https://orcid.org/0000-0003-3640-9185)
Institutions
- Ulsan College (KR)
- University of Ulsan (KR)
- Hanmi Pharmaceutical (South Korea) (KR)
- Inje University Haeundae Paik Hospital (KR)
- Ulsan University Hospital (KR)
Publication Details
- Journal
- Scandinavian Journal of Rheumatology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1080/03009742.2025.2566542
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00